Delivery Order SPE2DR25D2211-SPE2DR26FN4D2

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 11, 2026, with a ceiling value of $8,245.50 for HYPERRAB 300 unit/mL vial 5mL. This is a firm fixed-price delivery order under the Defense Logistics Agency Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...

<p>The Defense Logistics Agency issued a $1,649.10 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for HYPERRAB 300 Unit/ML Vial 5ML, with an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for $3,158.40 (firm fixed price) under the DLA Troop Support Medical indefinite delivery contract for HYPERRAB 300 unit/ml vial pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a $1,790.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vial (5ML) on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside contract, competitively awarded to support federal medical procurement needs. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary distribution operations. This delivery...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of HYPERRAB 300 Unit/ML vial in 5ML quantities, with a ceiling value of $8,668.70 and a completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...

The Defense Logistics Agency awarded a $3,354.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial on November 17, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9 billion...

This delivery order, awarded February 4, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, calls for the delivery of HYPERRAB 300 Unit/mL vial 5mL units with a ceiling value of $3,298.22 and a completion date of February 26, 2026. The award is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. HYPERRAB is an immunoglobulin...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for HYPERRAB 300 Unit/mL Vial 5mL at a ceiling value of $10,686.55 under a firm fixed price contract. This delivery order represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 24, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of HYPERRAB 300 Unit/ML Vials, with a ceiling value of $4,158.12 and an ultimate completion date of November 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 6, 2026, for hyperimmune rabies immunoglobulin (HYPERRAB 300 UNIT/ML, 5ML vials) with a ceiling value of $27,509.16. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 2, 2026. The delivery order was issued under the DLA Troop Support Medical IDC, a single-award indefinite delivery contract valued at up to $999,999,999.00 through...